Investigational Site

Düsseldorf 40479

0 studies enrolling now · 2 studies all time

What they study most

Anemia, Multiple Sclerosis, Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

Studies at this site

• Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden — Stopped early
• Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase — Completed